Data / Research funding / Nebraska / University of Nebraska Medical Center
University of Nebraska Medical Center: 362 NIH awards ($467.6M) and 5 NSF awards ($3.8M), fiscal years 2021 to 2026
University of Nebraska Medical Center in Omaha, NE is funded under 362 NIH awards ($467.6M) and 5 NSF awards ($3.8M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- G15AG3BLLMH4
- State
- Nebraska
Awards
367 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Great Plains IDeA-CTR | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $22,861,960 | September 1, 2016 | June 30, 2027 | RIZZO, MATTHEW | reporter.nih.gov |
| Nebraska Research Network in Functional Genomics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,833,603 | September 30, 2001 | April 30, 2026 | SORGEN, PAUL L | reporter.nih.gov |
| Tracking and Engaging Disconnected Long-Term Survivors of Childhood Cancer to Improve Adherence to Evidence-Based Screening Guidelines | NIH | National Cancer Institute | 2021 to 2025 | $14,573,097 | September 5, 1997 | August 31, 2026 | SWEASY, JOANN B. | reporter.nih.gov |
| Cognitive Neuroscience of Development and Aging (CoNDA) Center | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $13,774,095 | March 15, 2020 | May 31, 2030 | DUNAEVSKY, ANNA | reporter.nih.gov |
| Nebraska Center for Molecular Target Discovery and Development | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,120,081 | March 16, 2018 | June 30, 2028 | LEWIS, ROBERT E. | reporter.nih.gov |
| Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,243,787 | August 15, 2021 | June 30, 2027 | FOX, HOWARD S | reporter.nih.gov |
| Staphylococcal Biofilm and Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $7,012,434 | July 1, 2009 | June 30, 2024 | BAYLES, KENNETH W. | reporter.nih.gov |
| Nebraska Center for Heart and Vascular Research | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $5,207,382 | January 1, 2024 | December 31, 2028 | GUNDRY, REBEKAH L. | reporter.nih.gov |
| Pancreatic Cancer Detection Consortium | NIH | National Cancer Institute | 2021 to 2025 | $5,023,372 | May 1, 2017 | August 31, 2027 | HOLLINGSWORTH, MICHAEL A. | reporter.nih.gov |
| Alcohol Center Of Research -- Nebraska (ACORN) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $4,746,951 | February 28, 2023 | January 31, 2028 | CASEY, CAROL A. | reporter.nih.gov |
| Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease: An Investigation of STN LFP Biomarkers in Sleep Dysregulation and Repair | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,098,597 | February 17, 2025 | June 30, 2026 | ABOSCH, AVIVA | reporter.nih.gov |
| Monitoring real-world driver behavior for classification and early prediction of Alzheimer’s disease | NIH | National Institute on Aging | 2021 to 2024 | $4,023,312 | September 1, 1999 | February 28, 2026 | RIZZO, MATTHEW | reporter.nih.gov |
| A Bedside-to-Bench Approach to Pandemic Preparedness | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $3,906,967 | September 16, 2022 | February 28, 2025 | BAYLES, KENNETH W. | reporter.nih.gov |
| Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,810,605 | February 1, 2021 | January 31, 2028 | GUNDRY, REBEKAH L. | reporter.nih.gov |
| LASER ART for PreP | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,504,782 | April 12, 2021 | March 31, 2027 | GENDELMAN, HOWARD E | reporter.nih.gov |
| HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,451,500 | August 1, 2021 | June 30, 2027 | GORANTLA, SANTHI | reporter.nih.gov |
| Neuroprotective Immunity and HIV Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,351,926 | April 15, 1995 | February 29, 2028 | GENDELMAN, HOWARD E | reporter.nih.gov |
| Pancreatic Cancer Metastasis | NIH | National Cancer Institute | 2021 to 2022 | $3,255,692 | June 8, 2018 | May 31, 2025 | BATRA, SURINDER K. | reporter.nih.gov |
| Influence of Interpersonal Connectedness in Spousal Care Dyads on Early Progression of AD | NIH | National Institute on Aging | 2025 | $3,240,750 | September 15, 2025 | September 14, 2029 | CHEN, KUAN-HUA | reporter.nih.gov |
| The Impact of Environmental Stressors on Chronic Disease Disparities in Women | NIH | National Institute on Aging | 2021 to 2025 | $3,043,677 | July 15, 2021 | April 30, 2027 | PETERS, EDWARD S | reporter.nih.gov |
| Prodrug Formulations Create Sustained-Release Antiretrovirals | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,015,887 | July 1, 2019 | October 31, 2029 | EDAGWA, BENSON | reporter.nih.gov |
| Mobile Health-Targeted SARS-CoV-2 Testing and Community Interventions to Maximize Migrant Children's School Attendance During the COVID-19 Pandemic | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $2,999,995 | June 30, 2021 | June 29, 2025 | MCCULLOH, RUSSELL JAMES | reporter.nih.gov |
| Sex differences in BNST networks during early abstinence in AUD | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,988,793 | September 20, 2021 | July 31, 2027 | BLACKFORD, JENNIFER URBANO | reporter.nih.gov |
| Behavioral Economic and Staffing Strategies To Increase Adoption of the ABCDEF Bundle in the ICU (BEST-ICU) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,945,439 | April 1, 2024 | March 31, 2028 | BALAS, MICHELE CHRISTINA | reporter.nih.gov |
| Preventing invasive prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,928,553 | September 19, 2023 | August 31, 2028 | BERGAN, RAYMOND C. | reporter.nih.gov |
| Targeted lipid nanoparticles for gene therapeutics delivery approach to eradicating HIV reservoirs | NIH | National Institute of Mental Health | 2021 to 2025 | $2,789,702 | September 23, 2019 | February 28, 2030 | GENDELMAN, HOWARD E | reporter.nih.gov |
| Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,714,234 | August 12, 2022 | July 31, 2027 | PONNUSAMY, MOORTHY P. | reporter.nih.gov |
| Autophagy-mediated mucin degradation is necessary for resolution of mucous metaplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,704,621 | April 23, 2021 | March 31, 2027 | DICKINSON, JOHN DAVID | reporter.nih.gov |
| Impact of drugs of abuse on HIV brain reservoirs and HAND in humanized microglia mice | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,691,878 | July 15, 2021 | April 30, 2027 | GORANTLA, SANTHI | reporter.nih.gov |
| Strategies to define and mitigate the placental and fetal alterations caused by maternal oxycodone exposure | NIH | National Institute on Drug Abuse | 2023 | $2,655,006 | August 1, 2023 | July 31, 2026 | HARRIS, LYNDA KATHERINE | reporter.nih.gov |
| Gut bacterial metallophores in the development and severity of inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,638,713 | April 1, 2022 | February 28, 2027 | SAMUELSON, DERRICK R | reporter.nih.gov |
| Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,633,095 | August 10, 2011 | June 30, 2027 | CASEY, CAROL A. | reporter.nih.gov |
| Small Molecule Drug Discovery for CLN3 and CLN6 Disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,584,107 | September 20, 2021 | June 30, 2027 | TRIPPIER, PAUL | reporter.nih.gov |
| Nrf2 regulation of oxidative stress in heart failure and extra vesicular communication | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,552,315 | April 1, 2021 | March 31, 2026 | ZUCKER, IRVING H | reporter.nih.gov |
| Optimization of Antischistosomal Chemotypes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,501,475 | February 1, 2015 | March 31, 2026 | VENNERSTROM, JONATHAN L | reporter.nih.gov |
| Mechanisms of Gap Junction Regulation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,488,213 | June 1, 2006 | June 30, 2027 | SORGEN, PAUL L | reporter.nih.gov |
| Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma | NIH | National Cancer Institute | 2021 to 2025 | $2,481,931 | April 1, 2021 | March 31, 2027 | HOLSTEIN, SARAH A | reporter.nih.gov |
| New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,444,033 | March 10, 2022 | February 28, 2027 | OSNA, NATALIA ALEKSANDR | reporter.nih.gov |
| Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis | NIH | National Cancer Institute | 2021 to 2025 | $2,410,423 | August 1, 2021 | July 31, 2026 | IQBAL, JAVEED | reporter.nih.gov |
| MitoQ treatment of claudication: myofiber and micro-vessel pathology | NIH | National Institute on Aging | 2022 to 2025 | $2,389,785 | September 30, 2022 | May 31, 2027 | PIPINOS, IRAKLIS ILIAS | reporter.nih.gov |
| Coxiella survival mechanisms in the intracellular niche | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,351,632 | July 13, 2022 | June 30, 2027 | GILK, STACEY D | reporter.nih.gov |
| Mechanisms of membrane trafficking in endocytic and non-endocytic pathways | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,344,154 | May 1, 2022 | April 30, 2027 | CAPLAN, STEVEN H | reporter.nih.gov |
| T cell-innate immune crosstalk regulates Staphylococcus aureus craniotomy infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,305,198 | March 11, 2022 | February 28, 2027 | KIELIAN, TAMMY L | reporter.nih.gov |
| Nebraska Center for Nanomedicine | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $2,287,500 | June 1, 2018 | October 31, 2023 | OUPICKY, DAVID | reporter.nih.gov |
| Targeting MUC5AC mucin in breast cancer brain metastasis | NIH | National Cancer Institute | 2021 to 2025 | $2,276,402 | February 1, 2021 | January 31, 2027 | NASSER, MOHD WASIM | reporter.nih.gov |
| Discovery and characterization of selective D4R antagonists and their evaluation in preclinical models of PD-LIDs | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,271,548 | July 1, 2021 | June 30, 2027 | HOPKINS, COREY R. | reporter.nih.gov |
| Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,255,717 | August 1, 2022 | July 31, 2027 | DONG, JIXIN | reporter.nih.gov |
| Scar Detection and Treatment with Droplet Activation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,222,376 | April 1, 2020 | March 31, 2025 | PORTER, THOMAS R | reporter.nih.gov |
| Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,211,941 | December 20, 2019 | May 31, 2025 | JAIN, MANEESH | reporter.nih.gov |
| Connectivity mapping identified novel combination therapy for glioblastoma | NIH | National Cancer Institute | 2022 to 2025 | $2,198,374 | September 1, 2025 | August 31, 2027 | SHONKA, NICOLE | reporter.nih.gov |
| CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,186,007 | September 20, 2019 | August 31, 2025 | SARVETNICK, NORA E | reporter.nih.gov |
| Cerebral organoid and IPSC derived microglia: Modeling of HIV and methamphetamine co-morbidity | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,096,889 | September 1, 2022 | July 31, 2027 | YELAMANCHILI, SOWMYA | reporter.nih.gov |
| PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5 | NIH | National Institute of Mental Health | 2023 to 2025 | $2,072,244 | April 15, 2023 | January 31, 2028 | KANMOGNE, GEORGETTE D. | reporter.nih.gov |
| Skeletal Muscle Nrf2: Exercise-Induced Cardiovascular Protection | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,062,719 | January 15, 2022 | December 31, 2026 | GAO, LIE | reporter.nih.gov |
| Nebraska Pediatric Clinical Trials Unit | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $2,057,554 | September 23, 2016 | May 31, 2030 | KERNS, ELLEN | reporter.nih.gov |
| HEART Camp Connect: Promoting Adherence to Exercise in Adults with Heart Failure with Preserved Ejection Fraction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,042,468 | April 15, 2023 | March 31, 2028 | POZEHL, BUNNY | reporter.nih.gov |
| Impact of CLDN1 inhibition on chemoresistance and metastasis of colon cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,033,632 | February 12, 2021 | January 31, 2026 | DHAWAN, PUNITA | reporter.nih.gov |
| Ignite-Engage-Sustain: A Comprehensive Approach to Motivate, Involve, Educate, and Mentor Native American Students and Their Communities in Cancer Prevention, Treatment and Research | NIH | National Cancer Institute | 2021 to 2025 | $2,026,781 | September 20, 2017 | August 31, 2028 | IDOATE, REGINA EMILY | reporter.nih.gov |
| Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,984,415 | August 20, 2021 | June 30, 2026 | PATEL, KAUSHIK P | reporter.nih.gov |
| The role of hemoglobin alpha in diabetes-related vascular dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,962,468 | August 1, 2021 | July 31, 2027 | BAGHER, POONEH | reporter.nih.gov |
| NNTC Data Coordinating Center | NIH | National Institute of Mental Health | 2021 to 2022 | $1,961,991 | June 3, 2013 | February 29, 2024 | FOX, HOWARD S | reporter.nih.gov |
| Overcoming Resistance Mechanisms in Hedgehog and Myc-amplified Medulloblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,949,505 | December 1, 2020 | November 30, 2025 | MAHATO, RAM I. | reporter.nih.gov |
| Mechanisms of cardiac sympathetic hyperactivity in chronic heart failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,935,675 | July 1, 2017 | December 31, 2026 | LI, YU-LONG | reporter.nih.gov |
| GATA Factor Mechanisms in Erythroid Regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,916,875 | January 1, 2021 | September 30, 2026 | HEWITT, KYLE J | reporter.nih.gov |
| Mechanisms of Genome Instability in Tumors with DNA Polymerase Epsilon Mutations | NIH | National Cancer Institute | 2021 to 2024 | $1,909,663 | December 6, 2019 | November 30, 2025 | SHCHERBAKOVA, POLINA V | reporter.nih.gov |
| Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,904,596 | September 30, 2019 | July 31, 2025 | BUCH, SHILPA J. | reporter.nih.gov |
| Lipid nanomedicine targeting multiple signaling pathways of medulloblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,901,424 | July 15, 2022 | May 31, 2027 | MAHATO, RAM I. | reporter.nih.gov |
| Deciphering the Enzymatic Mechanism of Superoxide Dismutase | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,899,335 | August 1, 2022 | April 30, 2027 | BORGSTAHL, GLORIA | reporter.nih.gov |
| Neural Inflammation and Exercise Pressor Reflex in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,872,119 | August 16, 2023 | June 30, 2027 | WANG, HANJUN | reporter.nih.gov |
| Mechanisms of staphylococcal skin colonization | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,871,382 | March 22, 2022 | February 28, 2027 | FEY, PAUL D | reporter.nih.gov |
| Diastolic Heart Failure in HIV-1 infection | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,863,053 | July 15, 2022 | June 30, 2026 | BIDASEE, KESHORE R | reporter.nih.gov |
| Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,851,532 | September 7, 2022 | July 31, 2027 | WANG, DONG | reporter.nih.gov |
| Measuring neurodevelopmental effects of polygenic risk for Alzheimer's disease via longitudinal study of brain and cognitive variables in periadolescent children | NIH | National Institute on Aging | 2021 to 2023 | $1,851,031 | July 15, 2019 | April 30, 2025 | WARREN, DAVID E | reporter.nih.gov |
| Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures | NIH | National Cancer Institute | 2021 to 2025 | $1,827,310 | September 20, 2021 | August 31, 2027 | IQBAL, JAVEED | reporter.nih.gov |
| Use of radioprotector in rectal cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,812,623 | April 8, 2022 | January 31, 2028 | OBERLEY-DEEGAN, REBECCA E | reporter.nih.gov |
| Regulatory Role of Tandem Tryptophan Codons in Chlamydial Persistence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,807,001 | February 8, 2019 | January 31, 2025 | CARABEO, REY A | reporter.nih.gov |
| Effect of cell-based therapies on functional, hemodynamic, and histologic outcomes in a porcine model of peripheral arterial disease | NIH | National Institute on Aging | 2021 to 2023 | $1,779,273 | August 15, 2019 | March 31, 2025 | PIPINOS, IRAKLIS ILIAS | reporter.nih.gov |
| Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,750,136 | January 25, 2022 | December 31, 2026 | MAHATO, RAM I. | reporter.nih.gov |
| Optogenetic silencing to achieve antiarrhythmic effect of renal denervation in chronic heart failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,744,947 | August 28, 2023 | June 30, 2027 | LI, YU-LONG | reporter.nih.gov |
| OVERCOMING STROMAL BARRIERS TO THERAPEUTICS IN PANCREAS CANCER | NIH | National Cancer Institute | 2022 to 2025 | $1,733,335 | August 11, 2022 | May 31, 2027 | HINGORANI, SUNIL R | reporter.nih.gov |
| Leveraging PMN immune response to overcome ADT resistance in bone metastatic prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,731,077 | September 1, 2022 | August 31, 2027 | MATHEW, GRINU | reporter.nih.gov |
| Cardiac afferents and renal function in heart failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,714,995 | December 18, 2015 | December 31, 2024 | ZUCKER, IRVING H | reporter.nih.gov |
| Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,709,363 | July 10, 2020 | June 30, 2025 | XIE, JINGWEI | reporter.nih.gov |
| Role of alcohol-induced ghrelin in modulating organ crosstalk to promote the development of fatty liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,696,075 | June 15, 2021 | May 31, 2027 | RASINENI, KARUNA | reporter.nih.gov |
| Development of an NTSR1-Targeted Radiotherapeutic for Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,691,139 | April 1, 2021 | March 31, 2027 | GARRISON, JERED C | reporter.nih.gov |
| Fine-Scale Genome Folding Relative to Transcription and Location | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,632,925 | September 1, 2022 | June 30, 2027 | ROWLEY, MICHAEL JORDAN | reporter.nih.gov |
| Discovery and characterization of selective GIRK1/2 activators and their evaluation in preclinical models of pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,623,792 | April 1, 2022 | March 31, 2028 | HOPKINS, COREY R. | reporter.nih.gov |
| Aberrant DNA Repair and Lupus | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,618,709 | July 6, 2020 | March 31, 2028 | SWEASY, JOANN B. | reporter.nih.gov |
| Functional Analysis of the Clp Protease Systems in Chlamydial Growth and Differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,617,673 | July 1, 2022 | June 30, 2027 | OUELLETTE, SCOT P | reporter.nih.gov |
| Novel Neural Mechanisms underlying Lung-Heart Pathological Crosstalk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,617,138 | April 1, 2020 | March 31, 2025 | WANG, HANJUN | reporter.nih.gov |
| Aging trajectories and outcomes of older adults with acute myeloid leukemia | NIH | National Cancer Institute | 2023 to 2025 | $1,615,790 | July 12, 2023 | June 30, 2028 | BHATT, VIJAYA RAJ | reporter.nih.gov |
| Pathogenesis of Uveitis in Ebola Virus Disease Survivors | NIH | National Eye Institute | 2021 to 2023 | $1,611,656 | July 1, 2019 | June 30, 2025 | YEH, STEVEN | reporter.nih.gov |
| Collaborative Research: FEC: Converging AI, Biomechanics, and Genomics to Engineer Lodging Resilient Field Crops | NSF | Office of Integrative Activities | 2026 | $1,569,867 | August 1, 2026 | July 31, 2030 | Shibiao Wan | nsf.gov |
| Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,555,306 | February 10, 2019 | January 31, 2025 | OSNA, NATALIA ALEKSANDR | reporter.nih.gov |
| Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,552,302 | April 1, 2020 | February 28, 2026 | OUPICKY, DAVID | reporter.nih.gov |
| Patient-Specific Simulations to Guide Coronary Bifurcation Stenting | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,549,766 | April 15, 2019 | January 17, 2023 | CHATZIZISIS, IOANNIS S | reporter.nih.gov |
| Insight into the mechanism of action of the SSB interactome | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,543,993 | February 16, 2022 | January 31, 2027 | LYUBCHENKO, YURI L | reporter.nih.gov |
| Nanoscale assembly of amyloid oligomers at physiologically relevant conditions | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,538,303 | September 25, 2023 | June 30, 2027 | LYUBCHENKO, YURI L | reporter.nih.gov |
| Biomimetic and Injectable Highly Porous Nanofiber Microsphere-based Platform for Alveolar Bone Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2024 | $1,534,784 | June 8, 2022 | March 31, 2028 | XIE, JINGWEI | reporter.nih.gov |
| Defective Zn Homeostasis impairs host defense against pneumococcal pneumonia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,534,270 | December 22, 2021 | November 30, 2026 | KNOELL, DAREN LEE | reporter.nih.gov |
| HIV Tat and morphine-mediated pyroptosis activates astrocytes: Role of NLRP6 inflammasome in HAND | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,533,750 | August 1, 2020 | June 30, 2026 | PERIYASAMY, PALSAMY | reporter.nih.gov |
| Dose-Response Relationship and Pharmacokinetics of Intranasal Oxytocin on Neural Impact in Youths with High Levels of Irritability | NIH | National Institute of Mental Health | 2021 to 2022 | $1,531,256 | September 1, 2020 | February 28, 2025 | HWANG, SOONJO | reporter.nih.gov |
| Nanofiber-based Delivery of Combined Immune-modulating Compounds to Minimize Infection and Enhance Wound Healing | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,528,091 | May 1, 2017 | June 30, 2026 | XIE, JINGWEI | reporter.nih.gov |
| Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Center | NIH | National Institute of Mental Health | 2021 | $1,525,860 | September 30, 2000 | December 31, 2023 | FOX, HOWARD S | reporter.nih.gov |
| Encouraging Excellence: Health Science Education in Native American Communities | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,515,811 | April 25, 2021 | February 28, 2027 | GODFREY, MAURICE | reporter.nih.gov |
| Neuromuscular junction as a therapeutic target to improve post-traumatic outcomes | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,504,300 | July 1, 2022 | March 31, 2027 | LI, YU-LONG | reporter.nih.gov |
| Proteostasis in Plasmodium falciparum artemisinin resistance | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,493,872 | January 11, 2024 | November 30, 2028 | NG, CAROLINE L | reporter.nih.gov |
| The Role of the CBFB-MYH11 Complex in Leukemia Maintenance | NIH | National Cancer Institute | 2021 to 2024 | $1,488,680 | April 1, 2020 | March 31, 2026 | HYDE, RICIA KATHERINE | reporter.nih.gov |
| Stellate Ganglia Nrf2 Signaling and Enhanced Cardiac Sympathetic Tone in Chronic Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,483,024 | September 1, 2024 | August 31, 2028 | WANG, HANJUN | reporter.nih.gov |
| Community-Based Organizations and Development of Implementation Strategies for Brain Injury Screening Resulting from Intimate Partner Violence | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,471,674 | July 15, 2023 | May 31, 2027 | RAJARAM, SHIREEN SHEELA | reporter.nih.gov |
| Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,414,720 | March 20, 2023 | May 31, 2025 | KRISHNAN, MOHAN KUMAR | reporter.nih.gov |
| Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,409,090 | March 4, 2022 | February 28, 2027 | MOHS, AARON M. | reporter.nih.gov |
| Mechanisms of endosomal trafficking in lipid droplet catabolism | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,395,783 | July 15, 2023 | April 30, 2028 | SCHOTT, MICAH | reporter.nih.gov |
| Mechanisms underlying USP1-mediated bypass of EWS-FLI1 oncogene-induced replication stress in Ewing sarcoma | NIH | National Cancer Institute | 2022 to 2025 | $1,379,946 | August 5, 2022 | July 31, 2027 | GHOSAL, GARGI | reporter.nih.gov |
| UPR Activators for Cancer Therapy | NIH | National Cancer Institute | 2022 to 2025 | $1,379,375 | January 1, 2022 | July 31, 2025 | NATARAJAN, AMARNATH (AMAR) | reporter.nih.gov |
| Sex differences in modulating HIV/SIV reservoirs in the context of opioids | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,372,810 | September 1, 2024 | July 31, 2029 | BYRAREDDY, SIDDAPPA N | reporter.nih.gov |
| The Role of Astrocytes in the Fragile X Pathogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,371,795 | January 1, 2019 | December 31, 2024 | DUNAEVSKY, ANNA | reporter.nih.gov |
| Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment | NIH | National Cancer Institute | 2021 to 2023 | $1,351,610 | February 11, 2019 | January 31, 2026 | OUPICKY, DAVID | reporter.nih.gov |
| Mechanisms of iron-mediated renal injury in lupus nephritis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,331,974 | March 9, 2020 | January 31, 2026 | BOESEN, ERIKA INGRID | reporter.nih.gov |
| Development of Modular CRISPR Genome Editing Technologies and Tools | NIH | National Human Genome Research Institute | 2021 to 2023 | $1,318,204 | September 1, 2019 | June 30, 2025 | GURUMURTHY, CHANNABASAVAIAH | reporter.nih.gov |
| Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,308,543 | January 20, 2023 | December 31, 2027 | WANG, DONG | reporter.nih.gov |
| CFX Opus 96 Real-Time PCR System for precision genotyping and phenotyping | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,295,701 | September 1, 2021 | August 31, 2025 | YAN, YING | reporter.nih.gov |
| Fidelity Mechanisms of DNA Polymerase Beta | NIH | National Cancer Institute | 2024 to 2025 | $1,282,188 | March 7, 2024 | February 28, 2029 | SWEASY, JOANN B. | reporter.nih.gov |
| Mobile Health for Migrant Health (mHealth-4-Mhealth): Assessing the Effectiveness of Implementing an mHealth Program to Increase COVID-19 Testing and Treatment Among Rural Migrant Families | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $1,273,499 | August 15, 2024 | October 31, 2028 | MCCULLOH, RUSSELL JAMES | reporter.nih.gov |
| Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,258,700 | July 1, 2022 | March 31, 2027 | GHOSAL, GARGI | reporter.nih.gov |
| Nrf2 and the exaggerated Exercise Pressor Reflex in Peripheral Arterial Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,254,988 | December 11, 2023 | November 30, 2027 | WANG, HANJUN | reporter.nih.gov |
| Lysosome Trapped FAP-Targeted Theranostics for Pancreatic Cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,247,835 | March 18, 2024 | February 28, 2029 | GARRISON, JERED C | reporter.nih.gov |
| Regulation of Photoreceptor Neurotransmisssion | NIH | National Eye Institute | 2021 to 2023 | $1,244,869 | June 1, 1996 | January 31, 2025 | THORESON, WALLACE B | reporter.nih.gov |
| K channel, NLRP3 inflammasome and Meth exacerbation of HAND | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,234,632 | September 30, 2019 | June 30, 2025 | XIONG, HUANGUI HANK | reporter.nih.gov |
| Dose flexible ultra-long-acting prodrug formulations for pediatric populations | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,228,661 | January 17, 2025 | December 31, 2026 | EDAGWA, BENSON | reporter.nih.gov |
| AKR1C3 Inhibitors as Chemotherapeutic Potentiators | NIH | National Cancer Institute | 2021 to 2023 | $1,214,980 | January 1, 2019 | December 31, 2024 | TRIPPIER, PAUL | reporter.nih.gov |
| Potential mechanism underlying parasympathetic neuronal dysfunction in diabetes | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,206,652 | February 15, 2024 | January 31, 2028 | LI, YU-LONG | reporter.nih.gov |
| Functional relevance of C. trachomatis trp operon polymorphism | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,191,432 | August 19, 2024 | June 30, 2029 | CARABEO, REY A | reporter.nih.gov |
| Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,177,172 | April 1, 2023 | February 29, 2028 | MAHATO, RAM I. | reporter.nih.gov |
| A novel electric current-based treatment system for chronic wound biofilm infections | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $1,173,282 | July 7, 2023 | June 30, 2027 | ZHAO, SIWEI | reporter.nih.gov |
| Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,167,111 | July 1, 2019 | June 30, 2025 | OUPICKY, DAVID | reporter.nih.gov |
| Cancer Biology Training Program | NIH | National Cancer Institute | 2021 to 2025 | $1,153,393 | August 22, 1997 | June 30, 2030 | BLACK, JENNIFER D. | reporter.nih.gov |
| Whole-of-Community Systems Intervention for Youth Population Physical Activity | NIH | National Cancer Institute | 2021 to 2022 | $1,150,115 | January 4, 2018 | December 31, 2023 | DZEWALTOWSKI, DAVID A | reporter.nih.gov |
| Integrase Inhibitors during pregnancy and Neurodevelopmental Outcomes: Underlying Mechanism and Therapeutic Intervention | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,146,890 | May 15, 2024 | April 30, 2029 | BADE, ADITYA N | reporter.nih.gov |
| Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Transplantation (HCT) | NIH | National Institute on Aging | 2021 to 2025 | $1,140,812 | September 30, 2021 | August 31, 2026 | KOLL, THUY | reporter.nih.gov |
| Influence of ocular hypertension on neurons and synapses in the visual thalamus | NIH | National Eye Institute | 2021 to 2023 | $1,120,875 | September 1, 2019 | May 31, 2025 | VAN HOOK, MATTHEW JOHN | reporter.nih.gov |
| Extracellular vesicles, meth relapse and sex differences | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,120,035 | September 30, 2018 | June 30, 2024 | PENDYALA, GURUDUTT | reporter.nih.gov |
| The novel role of microtubule regulators in the DNA damage response | NIH | National Cancer Institute | 2021 to 2023 | $1,111,759 | January 1, 2021 | December 31, 2025 | PENG, AIMIN | reporter.nih.gov |
| Unexpected roles of phosphoinositides in the nucleus | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,104,922 | August 1, 2023 | July 31, 2028 | CHOI, SUYONG | reporter.nih.gov |
| Greatwall in replication stress/DNA damage responses and oral cancer resistance | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,086,491 | April 5, 2021 | October 23, 2023 | PENG, AIMIN | reporter.nih.gov |
| DNA Replication Machines: Structure-Function Studies | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $1,078,970 | January 1, 2024 | November 30, 2028 | TAHIROV, TAHIR H | reporter.nih.gov |
| Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients | NIH | National Cancer Institute | 2021 to 2022 | $1,030,727 | April 1, 2018 | August 31, 2025 | HOFFMAN, AMY JUDE | reporter.nih.gov |
| The role for alcohol-induced Golgi disorganization in the progression of prostate cancer | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,029,375 | August 2, 2019 | July 31, 2025 | PETROSYAN, ARMEN | reporter.nih.gov |
| Nuclear Neuropilin2: a novel molecular mediator for aggressive Prostate Cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,029,364 | April 1, 2020 | February 6, 2024 | DATTA, KAUSTUBH | reporter.nih.gov |
| Novel approach to attenuate small cell lung cancer growth and metastasis | NIH | National Cancer Institute | 2021 to 2022 | $1,027,744 | July 5, 2018 | June 30, 2024 | NASSER, MOHD WASIM | reporter.nih.gov |
| Epigenetic regulation of astrocyte-specific NLRP6 inflammasome and PANoptosis in HIV Tat and methamphetamine-mediated neuroinflammation | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,023,771 | July 1, 2024 | April 30, 2029 | PERIYASAMY, PALSAMY | reporter.nih.gov |
| Translesion synthesis DNA polymerases and genome instability | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,013,688 | July 1, 2009 | May 31, 2025 | SHCHERBAKOVA, POLINA V | reporter.nih.gov |
| SCH: A Multi-Modal Transfer Learning Framework to Maximize Health Outcomes for Breast Cancer | NSF | CSE - Core Programs | 2025 | $1,000,000 | August 1, 2025 | July 31, 2029 | Shibiao Wan | nsf.gov |
| CAREER: Understanding the Molecular Mechanisms of Insect Cuticular Chitin Maintenance | NSF | Cell Development & Physiology | 2024 | $981,784 | March 1, 2024 | February 28, 2029 | Sujata S Chaudhari | nsf.gov |
| Development of mechanism-based ovarian reserve protecting adjuvant therapies against gonadotoxic therapeutic agents | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $952,743 | September 9, 2019 | May 31, 2025 | KIM, SO-YOUN | reporter.nih.gov |
| Novel regulation of early follicle formation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $952,743 | July 1, 2019 | June 30, 2025 | ROY, SHYAMAL K. | reporter.nih.gov |
| HIV Tat and Opiate-mediated aberrations in glial-neuronal crosstalk: Implications for the role of extracellular RNA in HAND | NIH | National Institute on Drug Abuse | 2024 to 2025 | $942,270 | July 1, 2024 | April 30, 2029 | BUCH, SHILPA J | reporter.nih.gov |
| Human DNA Replication Machines: Structure-function Studies | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $915,000 | May 1, 2018 | April 30, 2023 | TAHIROV, TAHIR H | reporter.nih.gov |
| Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis | NIH | National Institute on Drug Abuse | 2025 | $898,025 | April 15, 2025 | February 28, 2030 | BYRAREDDY, SIDDAPPA N | reporter.nih.gov |
| Assessment of strategies for targeting transcriptional co-activators in colorectal cancer | NIH | National Cancer Institute | 2024 to 2025 | $885,766 | August 15, 2024 | July 31, 2029 | FISHER, KURT | reporter.nih.gov |
| PK/PD and Effect of T-5224 on HIV-1 Transcriptional Activity in an HIV-1-Mouse Model | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $862,359 | August 1, 2024 | October 31, 2025 | GORANTLA, SANTHI | reporter.nih.gov |
| Investigations of antiretroviral therapy penetration in cerebrospinal fluid | NIH | National Institute of Mental Health | 2021 to 2025 | $862,196 | March 5, 2021 | February 28, 2026 | AVEDISSIAN, SEAN | reporter.nih.gov |
| Regulation of RBP Function during EMT | NIH | National Cancer Institute | 2024 to 2025 | $853,791 | May 1, 2024 | April 30, 2029 | LEWIS, ROBERT E. | reporter.nih.gov |
| Coxiella manipulation of cholesterol in the intracellular niche | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $853,119 | May 1, 2018 | April 30, 2024 | GILK, STACEY D | reporter.nih.gov |
| Mechanistic studies of opiate withdrawal-induced sleep disturbances | NIH | National Institute on Drug Abuse | 2024 to 2025 | $828,900 | July 15, 2024 | April 30, 2029 | ZHONG, PENG | reporter.nih.gov |
| Mycobacterial trehalose metabolism as drug targets | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $827,395 | July 1, 2018 | June 30, 2025 | RONNING, DONALD R | reporter.nih.gov |
| Mechanisms by which phosphorylation and protein partners regulate Cx45 | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $826,580 | September 10, 2019 | June 30, 2025 | SORGEN, PAUL L | reporter.nih.gov |
| Immune mechanisms that promote S. aureus persistence during craniotomy-associated biofilm infection | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $824,424 | May 15, 2018 | March 31, 2023 | KIELIAN, TAMMY L | reporter.nih.gov |
| Development of siRNA conjugates for combination treatment of acute kidney injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $823,500 | September 20, 2018 | June 30, 2024 | OUPICKY, DAVID | reporter.nih.gov |
| UNMC Training Program in Alzheimer’s Disease and Related Dementias Drug Discovery | NIH | National Institute on Aging | 2022 to 2025 | $802,122 | June 1, 2022 | May 31, 2027 | TRIPPIER, PAUL | reporter.nih.gov |
| Targeting CXCR2 axis in Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2022 | $797,067 | March 6, 2018 | February 28, 2025 | SINGH, RAKESH K | reporter.nih.gov |
| Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training | NIH | National Cancer Institute | 2021 to 2022 | $793,337 | May 1, 2021 | June 30, 2022 | EHLERS, DIANE KRISTEN | reporter.nih.gov |
| Targeting P21 positive senescent cells for alleviating TMJ degeneration | NIH | National Institute of Dental & Craniofacial Research | 2024 to 2025 | $784,359 | September 5, 2024 | June 30, 2029 | YADAV, SUMIT | reporter.nih.gov |
| The Role of Complement in Cerebrospinal Fluid Shunt Infections | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $774,528 | May 1, 2020 | April 30, 2025 | SKAR, GWENN L | reporter.nih.gov |
| Investigating the function of bacterial cytoskeletal elements in the division and growth of the FtsZ-less Chlamydia | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $774,497 | July 15, 2024 | June 30, 2029 | OUELLETTE, SCOT P | reporter.nih.gov |
| Neuroimmunology of Disease Training Program | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $767,347 | July 1, 2018 | June 30, 2028 | MONAGHAN, DANIEL T | reporter.nih.gov |
| MMP-12 as an Endogenous Post-MI Resolution Promoting Factor | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $762,500 | February 1, 2019 | June 30, 2022 | LINDSEY, MERRY L. | reporter.nih.gov |
| Mechanisms of Presynaptic Energetic Failure Due to Age-Related Pathologic Tau Accumulation | NIH | National Institute on Aging | 2021 to 2022 | $762,500 | August 1, 2018 | June 30, 2024 | STAUCH, KELLY LYNN | reporter.nih.gov |
| Health Effects of E-cigarette Use on Brain Functions and Cognitive Development among Adolescents: A US Population-Based Study | NIH | National Institute on Drug Abuse | 2024 to 2025 | $760,870 | March 15, 2024 | January 31, 2028 | DAI, HONGYING DAISY | reporter.nih.gov |
| Discrimination and Racial Inequalities in Drug Use in U.S. Adults: Associations and Mechanisms | NIH | National Institute on Drug Abuse | 2023 to 2024 | $757,356 | June 15, 2023 | April 30, 2025 | DAI, HONGYING DAISY | reporter.nih.gov |
| Behavioral Economic and Staffing Strategies To Increase Adoption of the ABCDEF Bundle in the ICU (BEST-ICU) | NIH | National Heart, Lung, and Blood Institute | 2023 | $755,524 | April 15, 2023 | March 31, 2024 | BALAS, MICHELE CHRISTINA | reporter.nih.gov |
| The role of arginine catabolic pathways in modulating staphylococcal fitness | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $752,500 | November 6, 2017 | October 31, 2023 | THOMAS, VINAI | reporter.nih.gov |
| Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers | NIH | National Cancer Institute | 2023 to 2025 | $748,314 | May 9, 2016 | July 31, 2025 | NATARAJAN, AMARNATH (AMAR) | reporter.nih.gov |
| Redox Signaling and AMPK Crosstalk on Alcohol-Induced Multi-Organ Damage: Liver and Adipose TIssue | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $748,162 | September 1, 2024 | June 30, 2029 | VISWANATHAN, SARASWATHI | reporter.nih.gov |
| Synergy of lipolysis and lipophagy in alcoholic liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $747,000 | September 20, 2021 | August 31, 2025 | SCHOTT, MICAH | reporter.nih.gov |
| Genome-wide mechanisms and dynamics of ATP-dependent chromatin remodeling complexes | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $747,000 | April 1, 2021 | March 31, 2026 | BRAHMA, SANDIPAN | reporter.nih.gov |
| ARF6 function in cancers driven by RAS hyperactivation | NIH | National Cancer Institute | 2021 to 2023 | $741,981 | July 3, 2018 | August 31, 2025 | YOO, JAE HYUK | reporter.nih.gov |
| Human Disease Modeling of Glaucomatous Neuropathy | NIH | National Eye Institute | 2021 to 2022 | $739,625 | March 1, 2019 | February 28, 2025 | AHMAD, IQBAL | reporter.nih.gov |
| Induced pluripotent stem cell approach to optic nerve regeneration | NIH | National Eye Institute | 2021 to 2022 | $739,625 | December 1, 2012 | May 31, 2025 | AHMAD, IQBAL | reporter.nih.gov |
| Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer | NIH | National Cancer Institute | 2021 to 2022 | $737,469 | August 1, 2020 | September 30, 2022 | RACHAGANI, SATYANARAYANA | reporter.nih.gov |
| Mechanisms underlying dysregulated neuroimmune signaling and neuronal dysfunction in HIV (+) individuals with cART and cocaine | NIH | National Institute on Drug Abuse | 2021 to 2022 | $724,376 | September 30, 2018 | July 31, 2025 | BUCH, SHILPA J. | reporter.nih.gov |
| Critical Resources Provided by UNMC RAP Biorepository Stimulate Cancer Research | NIH | National Cancer Institute | 2021 to 2025 | $722,997 | September 15, 2016 | August 31, 2026 | GRANDGENETT, PAUL M | reporter.nih.gov |
| Behavioral and physiological linkage in people with frontotemporal dementia and spousal caregivers | NIH | National Institute on Aging | 2023 to 2025 | $722,719 | June 15, 2019 | December 31, 2025 | CHEN, KUAN-HUA | reporter.nih.gov |
| 3D Bioprinting of Biomimetic Constructs for Rotator Cuff Augmentation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $720,530 | June 1, 2018 | October 31, 2024 | DUAN, BIN | reporter.nih.gov |
| Synergistic Effect of Nicotine and Antiretrovirals on Placental Development | NIH | National Institute on Drug Abuse | 2025 | $718,374 | September 1, 2025 | May 31, 2030 | BADE, ADITYA N | reporter.nih.gov |
| Ultra-Small Epigenetic-Regulating Nanocarrier for Enhanced Synthetic Lethal Therapy | NIH | National Cancer Institute | 2024 to 2025 | $713,259 | July 9, 2024 | June 30, 2026 | SUN, JINGJING | reporter.nih.gov |
| Motivational Enhancement and Device Support Interventions to Increase Continuous Positive Airway Pressure Therapy Adherence in Adults with Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2024 | $707,556 | September 17, 2024 | August 31, 2025 | MILLER, JENNIFER NICOLE | reporter.nih.gov |
| FGFR4 intracellular domain promotes tumor progression in cholangiocarcinoma | NIH | National Cancer Institute | 2021 to 2022 | $689,636 | January 1, 2018 | December 31, 2023 | MOTT, JUSTIN L. | reporter.nih.gov |
| Cellular mechanisms of auditory processing deficits in a mouse model of Fetal Alcohol Spectrum Disorders | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $687,862 | May 17, 2024 | April 30, 2029 | RAGUNATHAN, PADMASHRI | reporter.nih.gov |
| A ratiometric fluorescent sensor array for bacterial pathogen investigation | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $679,387 | July 8, 2019 | March 31, 2025 | MOHS, AARON M. | reporter.nih.gov |
| Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1 | NIH | National Institute of Mental Health | 2021 | $676,262 | September 20, 2017 | July 31, 2024 | GENDELMAN, HOWARD E | reporter.nih.gov |
| Mechanisms of staphylococcal skin colonization | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $650,696 | September 15, 2021 | March 21, 2022 | FEY, PAUL D | reporter.nih.gov |
| Porcine Platforms For Technology Development In Pancreatic Cancer | NIH | National Cancer Institute | 2025 | $635,749 | December 19, 2024 | November 30, 2029 | HOLLINGSWORTH, MICHAEL A. | reporter.nih.gov |
| Fundamental Training Program in Biochemistry and Molecular Biology Research | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $633,138 | July 1, 2024 | June 30, 2029 | CAPLAN, STEVEN H | reporter.nih.gov |
| Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $629,146 | May 5, 2018 | March 31, 2025 | KHARBANDA, KUSUM K. | reporter.nih.gov |
| SIV reservoirs dynamics during aging | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $600,000 | August 15, 2024 | July 31, 2027 | ACHARYA, ARPAN | reporter.nih.gov |
| Uncovering pathogenic anti-bacterial defense mechanisms to identify novel targets for prevention of T1D | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $579,412 | July 1, 2017 | June 30, 2024 | SARVETNICK, NORA E | reporter.nih.gov |
| Immune drivers of oncogenic virus progression to cancer in people living with HIV | NIH | National Cancer Institute | 2025 | $544,250 | August 4, 2025 | July 31, 2030 | DICKEY, BRITTNEY | reporter.nih.gov |
| Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer | NIH | National Cancer Institute | 2021 | $530,254 | September 25, 2012 | May 11, 2022 | SINGH, PANKAJ KUMAR | reporter.nih.gov |
| Vulnerability of DHCR7+/- mutation carriers to aripiprazole and trazodone treatment | NIH | National Institute of Mental Health | 2021 | $524,246 | June 1, 2017 | May 31, 2022 | MIRNICS, KAROLY | reporter.nih.gov |
| Contribution of Glia to Sleep/Wake Disturbances in FXS | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $515,898 | April 1, 2025 | February 28, 2030 | DUNAEVSKY, ANNA | reporter.nih.gov |
| Innate Immunity to Viral Infection of the Retina | NIH | National Eye Institute | 2023 to 2025 | $507,944 | July 1, 2023 | July 31, 2025 | CONRADY, CHRISTOPHER DALE | reporter.nih.gov |
| Role of miR-146a in Abdominal Aortic Aneurysm | NIH | National Heart, Lung, and Blood Institute | 2025 | $504,671 | January 1, 2022 | December 31, 2026 | SUBRAMANIAN, VENKATESWARAN | reporter.nih.gov |
| Role of Intestinal Autophagy in the Pathogenesis of Alcohol Associated Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 | $500,255 | July 1, 2023 | September 30, 2023 | THOMES, PAUL GIDEON | reporter.nih.gov |
| Molecular interplay of HIV Tat, cocaine, and cART in microglial pyroptosis: Role of NLRP3 inflammasome | NIH | National Institute on Drug Abuse | 2025 | $490,172 | April 15, 2025 | January 31, 2030 | BUCH, SHILPA J | reporter.nih.gov |
| Parents helping Parents for Youth Vaping Cessation (PhP-VX) | NIH | National Cancer Institute | 2024 to 2025 | $481,491 | September 1, 2024 | August 31, 2027 | DAI, HONGYING DAISY | reporter.nih.gov |
| Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer | NIH | National Cancer Institute | 2021 | $477,871 | March 20, 2017 | May 11, 2022 | SINGH, PANKAJ KUMAR | reporter.nih.gov |
| Light-Sheet Fluorescence Microscope | NIH | Office of the Director, National Institutes of Health | 2021 | $477,301 | September 1, 2021 | August 31, 2023 | JENSEN-SMITH, HEATHER COLLEEN | reporter.nih.gov |
| The role of PGC1beta and ERRalpha as novel targets for therapy in colorectal cancer | NIH | National Cancer Institute | 2021 to 2022 | $475,164 | July 2, 2018 | June 30, 2023 | FISHER, KURT | reporter.nih.gov |
| Critical Analysis of Data-Rich Networks for Biomedical Scientists in Training. | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $456,552 | February 7, 2024 | April 30, 2025 | DUDLEY, ANDREW T | reporter.nih.gov |
| IL-1R1 in Endothelial-to-Mesenchymal Activation | NIH | National Heart, Lung, and Blood Institute | 2025 | $455,967 | March 1, 2024 | January 31, 2029 | ALFAIDI, MABRUKA | reporter.nih.gov |
| Mechanisms underlying prescription opioid use post social defeat in HIV+ adolescents | NIH | National Institute on Drug Abuse | 2023 to 2024 | $455,275 | May 1, 2023 | April 30, 2026 | PENDYALA, GURUDUTT | reporter.nih.gov |
| Development of a next-generation glycomics platform to enable glycan structure analyses for precision medicine | NIH | National Heart, Lung, and Blood Institute | 2021 | $451,037 | August 15, 2020 | July 31, 2023 | GUNDRY, REBEKAH L. | reporter.nih.gov |
| Omega-3 fatty acids induce macrophage IL-22 signaling to promote resolution of dust-induced lung inflammation | NIH | National Heart, Lung, and Blood Institute | 2025 | $447,889 | July 1, 2021 | June 30, 2027 | NORDGREN, TARA M | reporter.nih.gov |
| Supplement to Support the Acquisition of a High-Precision 3D Printer | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $445,118 | August 5, 2025 | November 30, 2025 | KUMBAR, SANGAMESH GURAPPA | reporter.nih.gov |
| Effects of Nicotine Concentration Levels in E-cigarettes on Biomarkers of Exposure to Toxicants and Tobacco Use Behaviors | NIH | National Institute on Drug Abuse | 2023 to 2024 | $441,792 | September 1, 2023 | August 31, 2025 | DAI, HONGYING DAISY | reporter.nih.gov |
| Development of optoelectronically active nerve adhesive for accelerating peripheral nerve repair | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $437,331 | September 22, 2023 | August 31, 2025 | DUAN, BIN | reporter.nih.gov |
| Racial disparities for the effects of parental marijuana use on youth marijuana and other substance use | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2024 | $435,829 | September 25, 2023 | June 30, 2025 | DAI, HONGYING DAISY | reporter.nih.gov |
| A novel and efficacious electrotaxis system for enhancing chronic wound healing | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $435,372 | August 13, 2025 | July 31, 2027 | ZHAO, SIWEI | reporter.nih.gov |
| Racial disparities in biomarkers, tobacco cessation, and smoking relapse in association with electronic cigarette use | NIH | National Institute on Drug Abuse | 2021 to 2022 | $435,003 | May 1, 2021 | April 30, 2024 | DAI, HONGYING DAISY | reporter.nih.gov |
| Developing an Astroglial Model for Fragile X Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $434,385 | August 1, 2021 | January 31, 2025 | DUNAEVSKY, ANNA | reporter.nih.gov |
| Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer | NIH | National Cancer Institute | 2021 | $434,065 | December 16, 2016 | May 11, 2022 | SINGH, PANKAJ KUMAR | reporter.nih.gov |
| Characterizing the Redoxome of Chlamydia and Its Host Cell | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $432,000 | August 17, 2023 | December 31, 2025 | OUELLETTE, SCOT P | reporter.nih.gov |
| Characterizing the Function of the Periplasmic Protease Tsp in Chlamydial Secondary Differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $429,500 | February 21, 2023 | January 31, 2026 | OUELLETTE, SCOT P | reporter.nih.gov |
| Examining HIV-mediated disruption of CNS immune homeostasis using a triple humanized mouse | NIH | National Institute of Mental Health | 2022 to 2023 | $422,125 | September 16, 2022 | August 31, 2025 | GORANTLA, SANTHI | reporter.nih.gov |
| Enhancement of Human Immune System Development in Mouse Models | NIH | Office of the Director, National Institutes of Health | 2022 to 2023 | $422,125 | July 1, 2022 | June 30, 2024 | POLUEKTOVA, LARISA Y | reporter.nih.gov |
| Coxiella secreted proteins mediating inter-organelle membrane contact sites | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $422,125 | November 4, 2022 | October 31, 2025 | GILK, STACEY D | reporter.nih.gov |
| Elucidating the Role of YAP and TAZ in the Aging Human Ovary | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $422,125 | August 7, 2023 | July 31, 2025 | DAVIS, JOHN S | reporter.nih.gov |
| Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $422,125 | August 16, 2023 | July 31, 2025 | WANG, HANJUN | reporter.nih.gov |
| Modulating granulocytic myeloid-derived suppressor cell (G-MDSC) metabolic activity to promote Staphylococcus aureus biofilm clearance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $422,125 | June 15, 2023 | May 31, 2025 | KIELIAN, TAMMY L | reporter.nih.gov |
| Brain metabolic imaging biomarkers of HIV-1 Infection During ART | NIH | National Institute of Mental Health | 2023 | $422,125 | August 15, 2023 | August 14, 2025 | LIU, YUTONG | reporter.nih.gov |
| Neurological Disorders in HIV-1 Infection | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $422,125 | August 15, 2024 | June 30, 2026 | BIDASEE, KESHORE R | reporter.nih.gov |
| Imaging Biomarker for Determining Antiretroviral-induced Neurodevelopmental Impairments | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $422,125 | July 1, 2025 | June 30, 2027 | BADE, ADITYA N | reporter.nih.gov |
| Functional mechanism underlying Dolutegravir (DTG)-associated developmental CNS abnormalities: Inhibition of matrix metalloproteinases activities | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $421,605 | September 20, 2021 | August 31, 2024 | BADE, ADITYA N | reporter.nih.gov |
| CNS HIV Theranostics Based on Intrinsic CEST Contrasts of Antiretroviral Drugs | NIH | National Institute of Mental Health | 2021 to 2022 | $421,552 | August 1, 2021 | July 31, 2024 | LIU, YUTONG | reporter.nih.gov |
| Macrophages and Microglia, Gene Expression and Chromatin: Illuminating the Myeloid Viral Reservoir in the Brain through Single Cell Analyses | NIH | National Institute of Mental Health | 2021 to 2022 | $421,375 | July 1, 2021 | June 30, 2023 | FOX, HOWARD S | reporter.nih.gov |
| Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia | NIH | National Cancer Institute | 2021 | $421,180 | March 6, 2017 | February 28, 2023 | PONNUSAMY, MOORTHY P. | reporter.nih.gov |
| Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5 | NIH | National Institute of Mental Health | 2021 to 2022 | $421,000 | December 1, 2020 | October 31, 2022 | KANMOGNE, GEORGETTE D. | reporter.nih.gov |
| Molecular Mechanism by which Notch Signaling regulates TMJ Osteoarthritis | NIH | National Institute of Dental & Craniofacial Research | 2025 | $419,379 | August 8, 2025 | May 31, 2030 | YADAV, SUMIT | reporter.nih.gov |
| Identifying novel immune determinants that influence S. aureus biofilm infection using Collaborative Cross (CC) mouse lines | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $417,845 | July 9, 2025 | June 30, 2027 | KIELIAN, TAMMY L | reporter.nih.gov |
| Adaptation of an in vitro generated human skin model for tick feeding to study Borrelia burgdorferi transmission and colonization | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $417,845 | August 1, 2025 | July 31, 2027 | BRINKWORTH, AMANDA J. | reporter.nih.gov |
| Characterizing the Function of Cyclic di-AMP on Chlamydial Growth and Differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $416,369 | June 20, 2024 | April 30, 2027 | OUELLETTE, SCOT P | reporter.nih.gov |
| Performance of the pooled testing strategy for detecting and estimating the prevalence and intensity of Schistosoma haematobium infection at a population level | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $416,324 | April 1, 2022 | March 31, 2025 | MENGIST, ABRAHAM | reporter.nih.gov |
| Defining ichthyosis in Sjogren-Larsson syndrome for clinical trial preparedness | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $415,073 | August 10, 2021 | July 31, 2024 | RIZZO, WILLIAM B. | reporter.nih.gov |
| Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $414,955 | August 15, 2017 | April 30, 2024 | PATEL, KAUSHIK P | reporter.nih.gov |
| Theory Assisted Design, Synthesis and Biological Activity of Bacteria-Targeting Nanostructures | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $410,713 | January 16, 2025 | November 30, 2025 | CONDA SHERIDAN, MARTIN MIGUEL | reporter.nih.gov |
| Overcoming drug resistance using small molecule activators of protein phosphatase 2A | NIH | National Cancer Institute | 2022 to 2023 | $405,919 | August 3, 2022 | July 31, 2025 | BLACK, JENNIFER D. | reporter.nih.gov |
| Non-ISGylated HIV proteins are sorted to hepatic exosomes to activate liver fibrosi | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $402,937 | August 8, 2024 | July 31, 2026 | OSNA, NATALIA ALEKSANDR | reporter.nih.gov |
| Mechanism of metabolic remodeling in the diabetic heart | NIH | National Heart, Lung, and Blood Institute | 2022 | $400,384 | September 22, 2022 | August 31, 2025 | MISHRA, PARAS KUMAR | reporter.nih.gov |
| Chlamydia trachomatis manipulates (PI)CALM to carry on | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $399,100 | September 4, 2024 | July 31, 2027 | RUCKS, ELIZABETH ANN | reporter.nih.gov |
| Novel Mechanisms Controlling SCLC Tumor Initiation | NIH | National Cancer Institute | 2021 to 2022 | $397,693 | August 1, 2021 | June 30, 2024 | LEWIS, ROBERT E. | reporter.nih.gov |
| Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in ALS | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $396,330 | February 1, 2017 | January 31, 2023 | WANG, XINGLONG | reporter.nih.gov |
| Optimization of MrgX1 allosteric agonists as potential therapies for chronic pain | NIH | National Institute on Drug Abuse | 2021 | $392,500 | September 15, 2017 | February 28, 2023 | HOPKINS, COREY R. | reporter.nih.gov |
| Co-targeting IGF-1R and Glutaminase in Ewing Sarcoma | NIH | National Cancer Institute | 2025 | $391,186 | September 1, 2025 | August 31, 2027 | BAND, HAMID | reporter.nih.gov |
| Development of a Theranostic Nanomedicine Construct for Ovarian Cancer | NIH | National Cancer Institute | 2021 | $390,858 | April 15, 2021 | March 31, 2023 | GARRISON, JERED C | reporter.nih.gov |
| ST6GalNAc-I/MUC5AC promoting angiogenesis in lung adenocarcinoma | NIH | National Cancer Institute | 2022 to 2023 | $387,014 | August 1, 2022 | July 31, 2025 | LAKSHMANAN, IMAYAVARAMBAN | reporter.nih.gov |
| HIV-1 mediated synaptodendritic injury and microglial activation: Role of extracellular vesicle miRNAs | NIH | National Institute of Mental Health | 2021 | $386,785 | December 20, 2016 | November 30, 2022 | BUCH, SHILPA J. | reporter.nih.gov |
| Mechanisms of lipid droplet trafficking in hepatocellular carcinoma | NIH | National Cancer Institute | 2023 to 2024 | $385,717 | June 2, 2023 | May 31, 2025 | SCHOTT, MICAH | reporter.nih.gov |
| Role of E3 Ligase UBR5 in Alternative Splicing during B Cell Development and Activation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $385,386 | August 25, 2021 | July 31, 2022 | BUCKLEY, SHANNON | reporter.nih.gov |
| Dissecting the Role Ubiquitin E3 Ligase UBR5 in Lymphomagenesis | NIH | National Cancer Institute | 2021 | $385,301 | August 1, 2021 | July 31, 2022 | BUCKLEY, SHANNON | reporter.nih.gov |
| Effects Of Environmental Challenges On Genetically Modified Interneuronal Subpopulations | NIH | National Institute of Mental Health | 2021 | $384,790 | July 1, 2003 | February 28, 2022 | MIRNICS, KAROLY | reporter.nih.gov |
| Molecular approach to ameliorate the age-dependent loss of Clock protein Bmal1 and Nrf2-antioxidant response in eye lens: Implications for eye lens health span | NIH | National Eye Institute | 2025 | $384,364 | September 1, 2025 | May 31, 2030 | SINGH, DHIRENDRA P | reporter.nih.gov |
| Targeting RHNO1 in Ovarian Cancer | NIH | National Cancer Institute | 2023 to 2024 | $383,923 | April 1, 2023 | March 31, 2026 | KARPF, ADAM R. | reporter.nih.gov |
| Novel antimicrobials to combat Gram-negative bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $383,750 | August 16, 2023 | July 31, 2025 | WANG, GUANGSHUN | reporter.nih.gov |
| Exploring the Molecular, Neuro-immune and Behavioral changes during HIV-associated progressive aging using a long-term humanized mice model | NIH | National Institute on Aging | 2024 | $383,750 | September 15, 2024 | August 31, 2025 | DASH, PRASANTA KUMAR | reporter.nih.gov |
| Chlamydial invasion of non-phagocytic cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $381,250 | July 1, 2005 | December 31, 2022 | CARABEO, REY A | reporter.nih.gov |
| Combinatorial effects of HIV, cART, & morphine on neuroinflammation: implications for HAND | NIH | National Institute on Drug Abuse | 2021 | $381,250 | July 1, 2017 | May 31, 2024 | BUCH, SHILPA J. | reporter.nih.gov |
| Potential therapies to improve ventricular vagal function in type 2 diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 | $381,250 | August 1, 2018 | July 31, 2024 | LI, YU-LONG | reporter.nih.gov |
| Medical Scientist Training Program at the University of Nebraska | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $381,240 | July 1, 2024 | June 30, 2029 | MOTT, JUSTIN L. | reporter.nih.gov |
| A Hydrogel Ionic Circuit-Based Electrical Stimulation System for Restoration of Denervated Muscles After Peripheral Nerve Injuries | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $378,094 | July 6, 2021 | June 30, 2024 | ZHAO, SIWEI | reporter.nih.gov |
| A Novel High-Intensity Iontophoresis-Based Antibiotic Delivery Device for Efficacious Eradication of Chronic Wound Biofilms | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $366,719 | June 3, 2022 | May 31, 2025 | ZHAO, SIWEI | reporter.nih.gov |
| Summer Undergraduate Alcohol Research Program | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $362,718 | March 15, 2012 | February 29, 2028 | BAILEY, KRISTINA L | reporter.nih.gov |
| Polysaccharide putty formulations for tissue regeneration | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $361,640 | May 1, 2025 | April 30, 2027 | KUMBAR, SANGAMESH GURAPPA | reporter.nih.gov |
| MUC16 in Pancreatic Cancer Progression and Metastasis | NIH | National Cancer Institute | 2021 | $338,280 | April 1, 2017 | March 31, 2023 | RADHAKRISHNAN, PRAKASH | reporter.nih.gov |
| Mechanisms of Complement Activation in Traumatic Injury | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $333,288 | September 15, 2024 | August 31, 2029 | BARRETT, CHRISTOPHER DAVID | reporter.nih.gov |
| Leveraging Alcohol Use Disorder Screening for Treatment in Routine Perioperative Care: AllUsCare | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $330,830 | September 20, 2024 | September 2, 2025 | BARTELS, KARSTEN | reporter.nih.gov |
| Prototype Mouse Models for SEND-Based mRNA Delivery and Technology Development | NIH | National Institute of General Medical Sciences | 2024 | $330,025 | September 18, 2024 | June 30, 2028 | GURUMURTHY, CHANNABASAVAIAH | reporter.nih.gov |
| Investigating the metastatic drive in pancreas cancer | NIH | National Cancer Institute | 2022 | $327,136 | August 9, 2018 | June 30, 2025 | HINGORANI, SUNIL R | reporter.nih.gov |
| Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $325,371 | April 1, 2018 | March 31, 2024 | PODANY, ANTHONY T | reporter.nih.gov |
| Polarized Chlamydial Cell Division in the Absence of FtsZ | NIH | National Institute of General Medical Sciences | 2021 | $320,528 | September 1, 2017 | August 31, 2022 | OUELLETTE, SCOT P | reporter.nih.gov |
| Role of Geroscience-Guided Therapeutics in Oral Health Problems of Aging | NIH | National Institute on Aging | 2022 to 2023 | $307,000 | September 1, 2022 | May 31, 2024 | CHEN, PO-JUNG | reporter.nih.gov |
| Targeting P21 positive senescent cells for alleviating TMJ degeneration | NIH | National Institute of Dental & Craniofacial Research | 2023 | $307,000 | August 11, 2023 | August 10, 2025 | YADAV, SUMIT | reporter.nih.gov |
| Impact of cannabidiol on HIV infection and methamphetamine abuse associated neuroinflammation | NIH | National Institute on Drug Abuse | 2024 to 2025 | $307,000 | April 1, 2024 | March 31, 2027 | CHAND, SUBHASH | reporter.nih.gov |
| Leveraging Heterogenous Common Fund Data Sets and Beyond for Identifying Lung Cancer Subtypes | NIH | Office of the Director, National Institutes of Health | 2024 | $307,000 | September 5, 2024 | September 4, 2025 | WAN, SHIBIAO | reporter.nih.gov |
| PARITY: An integrated community care and strengths-based technology intervention to improve maternal wellness and reduce health disparities in Black women | NIH | National Institute of Nursing Research | 2022 to 2023 | $304,641 | September 23, 2022 | July 31, 2025 | MOLLARD, ELIZABETH K | reporter.nih.gov |
| Metabolic Regulators of Corpus Luteum Function | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $304,148 | August 3, 2017 | April 30, 2024 | DAVIS, JOHN S | reporter.nih.gov |
| Vesicular Transport Mechanisms in Centrosome Regulation and Ciliogenesis | NIH | National Institute of General Medical Sciences | 2021 | $303,102 | May 1, 2020 | April 30, 2023 | CAPLAN, STEVEN H | reporter.nih.gov |
| Thrombocyte Regulation of Anti-Parasite Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $300,938 | February 1, 2024 | October 31, 2024 | BOTHWELL, ALFRED LM | reporter.nih.gov |
| RBC transfusion exacerbates brain inflammation in anemic murine neonates and causes long term neurodevelopment impairment | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $292,235 | December 18, 2024 | May 31, 2025 | KRISHNAN, MOHAN KUMAR | reporter.nih.gov |
| Ethanol suppresses HBV peptide-MHC Class I presentation on hepatocytes | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $273,420 | August 1, 2018 | October 20, 2023 | GANESAN, MURALI | reporter.nih.gov |
| Principals of Chromatin Organization | NIH | National Institute of General Medical Sciences | 2021 | $249,000 | April 1, 2018 | July 31, 2023 | ROWLEY, MICHAEL JORDAN | reporter.nih.gov |
| Molecular diagnostic and prognostic signatures for PTCL | NIH | National Cancer Institute | 2021 | $246,546 | April 1, 2017 | August 31, 2023 | IQBAL, JAVEED | reporter.nih.gov |
| Mechanisms by Which Alcohol-Induced Dysbiosis Impairs Host Defense Against Klebsiella Pneumoniae | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $246,208 | September 20, 2019 | August 31, 2023 | SAMUELSON, DERRICK R | reporter.nih.gov |
| The role of alcohol-associated microbiota membrane vesicles in mucosal immunity | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $230,980 | April 28, 2023 | April 27, 2026 | VILLAGELIU, DANIEL | reporter.nih.gov |
| Optogenetic modulation of cardiac vagal function improves prognosis in diabetes | NIH | National Heart, Lung, and Blood Institute | 2023 | $230,250 | February 1, 2023 | May 14, 2023 | ZHANG, DONGZE | reporter.nih.gov |
| Reversing disrupted developmental sterol biosynthesis by prescription medications | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $230,250 | September 1, 2024 | August 31, 2025 | MIRNICS, KAROLY | reporter.nih.gov |
| Mechanism of Dynein-mediated Early Intracellular Trafficking of Human Papillomavirus | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $230,250 | August 12, 2025 | July 31, 2027 | ZHANG, PENGWEI | reporter.nih.gov |
| Development of Transgenic Mouse Model Resources for Red Fluorescence-Based Genetically Encoded Indicator Studies | NIH | Office of the Director, National Institutes of Health | 2025 | $230,250 | July 1, 2025 | June 30, 2027 | BAGHER, POONEH | reporter.nih.gov |
| Crosslinking Action of Chlorpyrifos Oxon as Mechanism of Chronic Illness | NIH | National Institute of Environmental Health Sciences | 2021 | $228,750 | January 6, 2020 | June 30, 2022 | LOCKRIDGE, OKSANA | reporter.nih.gov |
| Improving Spinal Growth Modulation using a Novel Kyphotic Porcine Model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $222,970 | July 5, 2021 | October 25, 2022 | HALANSKI, MATTHEW A | reporter.nih.gov |
| Targeting FGFR4 to overcome chemoresistance in ovarian cancer | NIH | National Cancer Institute | 2024 | $215,284 | December 5, 2023 | June 30, 2024 | DONG, JIXIN | reporter.nih.gov |
| Knifeless Limb Lengthening: Critical Advancement of an Innovative Therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $214,866 | June 15, 2022 | May 31, 2023 | HALANSKI, MATTHEW A | reporter.nih.gov |
| Targeting PI3K/BRD4 and Hedgehog Pathway in Alcohol Associated Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $211,277 | September 22, 2021 | September 7, 2023 | KUMAR, VIRENDER | reporter.nih.gov |
| Intracellular IL-17 signaling during Coxiella burnetii infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $191,250 | July 1, 2020 | June 30, 2023 | GILK, STACEY D | reporter.nih.gov |
| Eradication of CNS HIV reservoirs through a first-in-class anti-tumor agent ONC201 | NIH | National Institute of Mental Health | 2021 | $191,250 | July 1, 2020 | February 28, 2023 | HUANG, YUNLONG | reporter.nih.gov |
| Roles of Hippo signaling and gap junctional communication in follicle development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $190,967 | September 1, 2021 | June 3, 2024 | CLARK, KENDRA L | reporter.nih.gov |
| Using optical sensors to measure synaptic glutamate release from retinal rod photoreceptor cells | NIH | National Eye Institute | 2025 | $190,538 | January 1, 2025 | December 31, 2026 | THORESON, WALLACE B | reporter.nih.gov |
| Evaluating mycothiolation of xenobiotics | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $186,425 | April 1, 2020 | March 31, 2023 | RONNING, DONALD R | reporter.nih.gov |
| Targeting pyrimidine biosynthesis in pancreatic ductal adenocarcinoma | NIH | National Cancer Institute | 2021 to 2024 | $180,660 | July 12, 2021 | July 11, 2025 | MULLEN, NICHOLAS JAMES | reporter.nih.gov |
| Flupirtine Analogue Synthesis and Screening for the Treatment of Chemotherapy-Induced Neuropathic Pain | NIH | National Cancer Institute | 2025 | $179,403 | April 1, 2025 | March 31, 2027 | DUAN, BIN | reporter.nih.gov |
| Inflammatory Responses, Fibrotic Mediators, and Comorbidity Burden as Determinants of Myocardial Dysfunction and Heart Failure in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $172,034 | August 15, 2025 | June 30, 2030 | JOHNSON, TATE | reporter.nih.gov |
| REM sleep control by the sublaterodorsal tegmental nucleus glutamatergic neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $168,182 | February 1, 2023 | April 30, 2024 | ZHONG, PENG | reporter.nih.gov |
| SPARKLED: Do After School Programs Affect Risk in Kids of Latent Endothelial Disease | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $167,208 | June 19, 2022 | May 31, 2027 | DRAKOWSKI, REBECCA ANNE | reporter.nih.gov |
| Osteoarthritis After ACL Injury: Establishing Cumulative Joint Loading as a Preventative Target | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $166,954 | February 25, 2020 | January 31, 2023 | WELLSANDT, ELIZABETH A | reporter.nih.gov |
| TREM2 senses both pathogen- and damage-associated molecular patterns to promote S. aureus craniotomy infection | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $164,598 | May 10, 2022 | August 9, 2024 | KORSHOJ, LEE ERIK | reporter.nih.gov |
| RBC TRANSFUSION IN ANEMIC NEONATES LEADS TO SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $158,965 | May 1, 2023 | July 31, 2024 | KRISHNAN, MOHAN KUMAR | reporter.nih.gov |
| SOX2-MYC Axis: Transcriptional Repression of the MYC Oncogene by SOX2 | NIH | National Cancer Institute | 2022 to 2023 | $153,500 | August 1, 2022 | July 31, 2024 | RIZZINO, A. ANGIE | reporter.nih.gov |
| PIP5K1A is a novel mutant KRAS effector and essential for pancreatic cancer cell survival | NIH | National Center for Advancing Translational Sciences | 2023 | $153,500 | July 1, 2023 | June 30, 2024 | CHOI, SUYONG | reporter.nih.gov |
| Vascular remodeling in the ovary | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $153,500 | August 4, 2023 | July 31, 2025 | DAVIS, JOHN S | reporter.nih.gov |
| Enhancing uptake of preconception care services in family practice clinics using a patient centered screening tool: A Pilot Study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $153,500 | September 22, 2023 | August 31, 2025 | MALONEY, SHANNON I | reporter.nih.gov |
| HIV Tat and alcohol-mediated activation of astrocytes involves ER stress/NLRP6 inflammasome axis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $153,500 | March 15, 2024 | February 28, 2026 | SINGH, SEEMA | reporter.nih.gov |
| DNA ligase activities during base excision repair coordination | NIH | National Institute of General Medical Sciences | 2025 | $153,365 | August 15, 2022 | May 31, 2027 | CAGLAYAN, MELIKE | reporter.nih.gov |
| Co-Oncogenic Role of ECD in HER2-Driven Breast Cancer | NIH | National Cancer Institute | 2021 to 2022 | $153,292 | September 1, 2021 | August 31, 2023 | BAND, VIMLA | reporter.nih.gov |
| EAGER: Collaborative Research: Embedded Section-by-Section Bioprinting (ESB) of Large-Scale Cellular Human Tissue Constructs | NSF | Civil, Mechanical, & Manufacturing Innovation | 2025 | $149,826 | August 1, 2025 | July 31, 2027 | Bin Duan | nsf.gov |
| Notch Signaling in the Regulation of TMJ Osteoarthritis | NIH | National Institute of Dental & Craniofacial Research | 2022 | $133,999 | June 22, 2023 | August 31, 2025 | YADAV, SUMIT | reporter.nih.gov |
| NINDS SCIENTIFIC RESEARCH PREPARATORY SUMMER COURSE PROGRAM - AMERICAN INDIAN/ALASKA NATIVE (AI/AN) | NIH | National Institute on Drug Abuse | 2025 | $130,229 | May 6, 2024 | May 5, 2026 | STONER, JULIE A | reporter.nih.gov |
| Neuroimmune contributions to hypertension sensitization in a preclinical model of PTSD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $119,579 | September 1, 2020 | May 31, 2024 | ELKHATIB, SAFWAN KIJANA | reporter.nih.gov |
| Targeting Disease Specific Tn Antigen in Pancreatic Cancer | NIH | National Cancer Institute | 2025 | $117,777 | December 20, 2024 | April 30, 2025 | RADHAKRISHNAN, PRAKASH | reporter.nih.gov |
| Molecular control of tumor-initiating cells in Ras-driven cancers | NIH | National Cancer Institute | 2023 to 2025 | $116,179 | July 1, 2023 | June 30, 2026 | VIEIRA, HEIDI | reporter.nih.gov |
| Oncogenic insults within the pancreatic ductal glands produce pre-malignant lesions and PDAC | NIH | National Cancer Institute | 2023 to 2025 | $115,138 | April 1, 2023 | March 31, 2026 | MCANDREWS, KYLE | reporter.nih.gov |
| Cellular Senescence in mediating age related TMJ Degeneration | NIH | National Institute of Dental & Craniofacial Research | 2022 | $109,736 | June 16, 2023 | May 31, 2025 | YADAV, SUMIT | reporter.nih.gov |
| The Effect of Pubertal Hormones on the Development of Neural Oscillatory Dynamics in Youth | NIH | National Institute of Mental Health | 2024 to 2025 | $108,512 | September 13, 2024 | September 12, 2026 | KILLANIN, ABRAHAM | reporter.nih.gov |
| Understanding the developmental impact of environmental risk factors on brain and cognitive systems vulnerable to Alzheimers disease in children | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $100,512 | September 17, 2024 | August 31, 2026 | RAMIREZ, MEGHAN | reporter.nih.gov |
| Novel Models and Biorepository For Early Detection And Therapeutic Intervention Of Pancreatic Cancer | NIH | National Cancer Institute | 2025 | $97,305 | September 1, 2025 | August 31, 2030 | MALLYA, KAVITA | reporter.nih.gov |
| The impact of chronic cannabis use on neuromagnetic activity in persons living with HIV | NIH | National Institute on Drug Abuse | 2021 to 2022 | $90,748 | July 1, 2019 | June 30, 2023 | LEW, BRANDON J. | reporter.nih.gov |
| A SMART Design to Improve Sleep Disturbance in Adolescents with Neurodevelopmental Disorders | NIH | National Institute of Nursing Research | 2021 | $89,613 | February 1, 2019 | January 31, 2023 | HANISH, ALYSON E | reporter.nih.gov |
| Hepatocyte-hepatic stellate cell axis in potentiation of alcohol and HIV-induced liver injury | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $85,951 | February 5, 2021 | December 16, 2022 | NEW-AARON, MOSES O | reporter.nih.gov |
| Negative reinforcement in early abstinence from an alcohol use disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 | $79,456 | December 1, 2024 | November 30, 2026 | ZABIK, NICOLE LAUREN | reporter.nih.gov |
| Silencing B7-H3 mitigates tumor aggressiveness in group 3 medulloblastoma | NIH | National Cancer Institute | 2025 | $76,750 | January 1, 2025 | December 31, 2026 | MAHAPATRA, SIDHARTH | reporter.nih.gov |
| Targeting the ACOD1 immunometabolic pathway of lung myeloid cells to reduce environmental exposure-induced lung disease | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $76,018 | January 15, 2024 | December 31, 2025 | SCHWAB, AARON | reporter.nih.gov |
| Measuring neurodevelopmental effects of genetic risk for Alzheimer's disease via cross-sectional study of brain, cognitive, and physical fitness variables in periadolescent children | NIH | National Institute on Aging | 2024 to 2025 | $76,018 | June 1, 2024 | June 16, 2028 | HELLER-WIGHT, ABI | reporter.nih.gov |
| Defining the persistence associated transcriptome in Chlamydia trachomatis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $71,822 | July 21, 2021 | June 30, 2023 | HATCH, NATHAN D. | reporter.nih.gov |
| Elucidation of the Role of Chlamydial ClpX During Development and Differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $67,820 | July 21, 2021 | May 5, 2023 | WOOD, NICHOLAS A | reporter.nih.gov |
| Mechanistic studies of stalled DNA replication fork rescue | NIH | National Institute of General Medical Sciences | 2021 | $60,174 | June 7, 2013 | April 30, 2022 | BIANCO, PIERO R | reporter.nih.gov |
| The impact of alcohol-induced ATF6-mediated ER stress and Golgi disorganization on pro-metastatic glycosylation of integrins in prostate cancer | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2024 | $59,099 | September 1, 2023 | May 10, 2025 | MACKE, AMANDA JESSIE | reporter.nih.gov |
| Impact of Trauma on the Longitudinal Development of Cognitive Control Networks in Healthy Youth | NIH | National Institute of Mental Health | 2025 | $54,538 | May 30, 2023 | May 29, 2027 | SON, JAKE | reporter.nih.gov |
| Aberrant cortical entrainment in biomarker-confirmed Alzheimer's disease and mild cognitive impairment | NIH | National Institute on Aging | 2025 | $50,514 | January 12, 2022 | January 11, 2027 | SPRINGER, SETH D | reporter.nih.gov |
| I-Corps: Translation Potential of an Automated Dynamic Antibiogram | NSF | Pathways for Translation Section | 2025 | $50,000 | May 15, 2025 | April 30, 2027 | Bradford A Becken | nsf.gov |
| Nitrogen Metabolism of Staphylococcus aureus | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $45,574 | February 2, 2025 | February 1, 2030 | BURKE, TAYLOR LAUREN | reporter.nih.gov |
| Targeting metabolic remodeling and mitochondrial dysfunction in the diabetic heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $43,131 | February 1, 2021 | May 31, 2022 | KAMBIS, TYLER N | reporter.nih.gov |
| Tumor-cell intrinsic and extrinsic determinants of drug resistance and metastasis | NIH | National Cancer Institute | 2024 to 2025 | $41,693 | September 1, 2024 | May 31, 2025 | PRIMEAUX, MARK | reporter.nih.gov |
| Defining Mechanisms of SAMD1 in Hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2024 | $38,549 | July 10, 2024 | July 9, 2026 | SCHAEFER, MEG | reporter.nih.gov |
| Annual meeting of the American Society for Rickettsiology | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $22,000 | July 5, 2024 | June 30, 2027 | GILK, STACEY D | reporter.nih.gov |
| Infarct macrophage secretome components coordinate neutrophil degranulation and attenuate wall thinning | NIH | National Heart, Lung, and Blood Institute | 2021 | $20,556 | March 1, 2021 | October 31, 2021 | DASEKE, MICHAEL J | reporter.nih.gov |
| Anti-Hypertensive Properties of the Antioxidant, MnTnBuOE-2-PyP5+, and its Nanoformulation | NIH | National Heart, Lung, and Blood Institute | 2021 | $19,119 | December 15, 2020 | August 13, 2021 | SCHLICHTE, SARAH L | reporter.nih.gov |
| Cardiovascular Outcomes Research in Perioperative Medicine - COR-PM | NIH | National Heart, Lung, and Blood Institute | 2022 | $10,000 | November 23, 2021 | October 31, 2022 | BARTELS, KARSTEN | reporter.nih.gov |
| Role of Lysosome Damage in ALD Pathogenesis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 | $1 | September 15, 2023 | September 30, 2023 | THOMES, PAUL GIDEON | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $1,569,867 |
| 2025 | 172 | $93,560,885 | 4 | $1,701,083 |
| 2024 | 175 | $88,731,696 | 1 | $480,527 |
| 2023 | 178 | $98,367,650 | 0 | $0 |
| 2022 | 184 | $96,792,700 | 0 | $0 |
| 2021 | 174 | $90,118,456 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 8 awards here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 41 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 41 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 41 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 41 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 41 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 41 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 41 awards here |
Topics of its NIH awards
- Neurosciences
- Infectious Diseases
- Genetics
- Cancer
- Rare Diseases
- Biotechnology
- Brain Disorders
- Clinical Research
- Digestive Diseases
- Bioengineering
- Prevention
- Behavioral and Social Science
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.